Meeting
2012 ASCO Annual Meeting
Use of next-generation sequencing (NGS) to detect a novel ALK fusion and a high frequency of other actionable alterations in colorectal cancer (CRC).
Authors
Jeffrey S. Ross
Albany Medical College, Albany, NY
Jeffrey S. Ross , Doron Lipson , Christine E Sheehan , Geoff Otto , Roman Yelensky , Alex Parker , Mirna Jarosz , Frank Juhn , Tina Brennan , Sean Downing , Amy Donahue , Sohail Balasubramanian , Gary A. Palmer , Vincent A. Miller , Philip Stephens , Maureen T. Cronin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3533)
DOI
10.1200/jco.2012.30.15_suppl.3533
Abstract #
3533
Poster Bd #
25
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of appendiceal adenocarcinoma.
First Author: Kanwal Pratap Singh Raghav
Poster
2023 ASCO Annual Meeting
Characterization of MCL-1 in patients with colorectal cancer (CRC): Expression, molecular profiles, and outcomes.
First Author: Pooja Mittal
Poster
2022 ASCO Annual Meeting
Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.
First Author: Zhouhuan Dong
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari